MEGHAN GOULD: Open Payments
NPI 1043950793 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 23 payments from 9 companies in 2025. Trend: 2023 $21 · 2024 $24 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $222 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| ABBVIE INC. | 3 | $63 |
| Aimmune Therapeutics, Inc. | 2 | $61 |
| Novo Nordisk Inc | 2 | $47 |
| Corcept Therapeutics | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $19 |
| Viatris Specialty LLC | 1 | $18 |
Products named: FARXIGA, BREZTRI, ZENPEP, TRELEGY ELLIPTA, AIRSUPRA, BEXSERO, UBRELVY, VRAYLAR.
Industry payments across RI — which companies pay providers there.
